[Significens of blood platelet CD62p in treating sudden deafness].
OBJECTIVE
To compare different treatment methods for sudden deafness of different blood platelet CD62p levels.


METHODS
Blood platelet was measured with flow cytometer. Patients with platelet CD62p over or less than 2% were treated with routine treatment (low molecular weight dextran, ATP, CoA and dexamethasone) or routine treatment plus batroxobin (thrombolysis) separately.


RESULTS
In the group with platelet CD62p > or = 2%, the effective rates of routine treatment was 60.5%, and that of routine treatment plus thrombolysis was 84.6%. There was significant difference between them. In the group with platelet CD62p < 2%, the effective rates of two methods were 65.0% and 71.8% respectively(no significant difference between them).


CONCLUSIONS
Detecting CD62p in sudden deafness patients makes sense for deciding treatment project.
Zhang
Qinna
Q
Department of Otorhinolaryngology, First Hospital of Shanxi Medical University, Taiyuan 030001, China. cxbxx@public.ty.sx.cn
Zhang
Liping
L
Xia
Lijun
L
Chen
Yanqiu
Y
Wang
Jianming
J
Wang
Binquan
B
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D003639:Hearing Loss, Sudden / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019007:P-Selectin / Q000097:blood*; D015539:Platelet Activation; D015912:Thrombolytic Therapy
D019007:P-Selectin